Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer (vol 71, pg 6738, 2011)

被引：0
|
作者：
Zhang, C.
Wang, L.
Wu, D.
Chen, H.
Thomas-Ahner, J.M.
机构：
来源：
CANCER RESEARCH | 2011年 / 71卷 / 24期
关键词：
D O I：
10.1158/0008-5472.CAN-11-3698
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7718 / 7718
页数：1
相关论文
共 29 条
  • [21] Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study (vol 83, pg 15, 2023)
    Yu, Evan Y.
    Piulats, Josep M.
    Gravis, Gwenaelle
    Fong, Peter C. C.
    Todenhoefer, Tilman
    Laguerre, Brigitte
    Arranz, Jose A.
    Oudard, Stephane
    Massard, Christophe
    Heinzelbecker, Julia
    Nordquist, Luke T.
    Carles, Joan
    Kolinsky, Michael P.
    Augustin, Marinela
    Gurney, Howard
    Tafreshi, Ali
    Li, Xin Tong
    Qiu, Ping
    Poehlein, Christian H.
    Schloss, Charles
    de Bono, Johann S.
    [J]. EUROPEAN UROLOGY, 2023, 83 (03) : E87 - E87
  • [22] RETRACTION: miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells (Retraction of Vol 67, Pg 380, 2015)
    Zhao, Jian-Li
    Zhang, Le
    Guo, Xu
    Wang, Jing-Hua
    Zhou, Wen
    Liu, Min
    Li, Xin
    Tang, Hua
    [J]. IUBMB LIFE, 2024, 76 (06) : 363 - 363
  • [23] GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol) (vol 14, pg 1, 2022)
    Conduit, C.
    Mak, B.
    Qu, W.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [24] Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway (vol 24, pg 1804, 2020)
    Chen, Song
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (13) : 3803 - 3804
  • [25] hsa_circ_0001018 promotes papillary thyroid cancer by facilitating cell survival, invasion, G1/S cell cycle progression, and repressing cell apoptosis via crosstalk with miR-338-3p and SOX4 (vol 24, pg 591, 2021)
    Luo, Qiang
    Guo, Feng
    Fu, Qingfeng
    Sui, Guoqing
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 27 : 593 - 597
  • [26] MIMOSINE, A REVERSIBLE G1/S PHASE-BOUNDARY CELL-CYCLE INHIBITOR, DECREASES P34CDC2/P58CYCLIN A PROLINE-DIRECTED PROTEIN-KINASE ACTIVITY IN MDA-MB-453 BREAST-CANCER CELLS
    KULP, KS
    BERARDI, CJ
    VULLIET, PR
    [J]. FASEB JOURNAL, 1992, 6 (05): : A1933 - A1933
  • [27] Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with Cell Growth Inhibition and G1/S Phase Arrest in Human Non-Small-Cell Lung Cancer Cell Lines (Retraction of vol 72, pg 248, 2007)
    Ling, Y-H
    Li, T.
    Yuan, Z.
    Haigentz, M., Jr.
    Weber, T. K.
    Perez-Soler, R.
    [J]. MOLECULAR PHARMACOLOGY, 2015, 88 (02) : 390 - 390
  • [28] LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway (vol 372, pg 239, 2016)
    Li, ZhiZhen
    Chen, YuanYuan
    Wang, XuAn
    Zhang, HongChen
    Zhang, Yijian
    Gao, YaoHui
    Weng, Mingzhe
    Wang, Lei
    Liang, HaiBin
    Li, MaoLan
    Zhang, Fei
    Zhao, Shuai
    Liu, Shibo
    Cao, Yang
    Shu, Yijun
    Bao, Runfa
    Zhou, Jian
    Liu, Xiyong
    Yan, Yun
    Zhen, Lei
    Dong, Qian
    Liu, Yingbin
    [J]. CANCER LETTERS, 2016, 376 (01) : 197 - 198
  • [29] RETRACTED: Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Retracted article. See vol. 88, pg. 390, 2015)
    Ling, Yi-He
    Li, Tianhong
    Yuan, Ziqiang
    Haigentz, Missak, Jr.
    Weber, Thomas K.
    Perez-Soler, Roman
    [J]. MOLECULAR PHARMACOLOGY, 2007, 72 (02) : 248 - 258
123